SHENZHEN SAIYASI TECHNOLOGY CO., LTD. – Trademark Portfolio

Entity Type: 99

SHENZHEN SAIYASI TECHNOLOGY CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include NOEEOI. The owner is based in SHENZHEN.

ROOM 211, BUILDING D, BANTIAN INTERNATIONAL CENTER, NO. 5, HUANCHENG SOUTH ROAD, MA'ANTANG COMMUNITY, BANTIAN STREET, LONGGANG DISTRICT

SHENZHEN , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

NOEEOI
NOEEOI
Registered 2024

Trademark Classifications

SHENZHEN SAIYASI TECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does SHENZHEN SAIYASI TECHNOLOGY CO., LTD. have?

SHENZHEN SAIYASI TECHNOLOGY CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does SHENZHEN SAIYASI TECHNOLOGY CO., LTD. file in?

SHENZHEN SAIYASI TECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are SHENZHEN SAIYASI TECHNOLOGY CO., LTD.'s most well-known trademarks?

SHENZHEN SAIYASI TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as NOEEOI. These are among 1 currently registered trademark in the portfolio.

What is SHENZHEN SAIYASI TECHNOLOGY CO., LTD.'s trademark registration success rate?

SHENZHEN SAIYASI TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.